ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
374 hedge funds and large institutions have $6.62B invested in Intra-Cellular Therapies Inc. in 2024 Q2 according to their latest regulatory filings, with 76 funds opening new positions, 142 increasing their positions, 126 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
374
Holders Change
+31
Holders Change %
+9.04%
% of All Funds
5.44%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
76
Increased
142
Reduced
126
Closed
42
Calls
$28.9M
Puts
$26.5M
Net Calls
+$2.4M
Net Calls Change
-$215M
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
$235M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
$95.5M |
| 3 |
Westfield Capital Management
Boston,
Massachusetts
|
$71.4M |
| 4 |
Invesco
Atlanta,
Georgia
|
$201M |
| 5 |
PA
Perceptive Advisors
New York
|
$118M |
